相似文献
1
Calcium Pyrophosphate Crystal Inflammatory Arthritis (Pseudogout) with Myelodysplastic Syndrome: A New Paraneoplastic Syndrome?
J Rheumatol. 2017 Jul;44(7):1101-1102. doi: 10.3899/jrheum.170106.
2
Pseudogout as a clue and complication in primary hyperparathyroidism.
Surgery. 1989 Dec;106(6):1036-41, discussion 1041-2.
3
Calcium pyrophosphate dihydrate crystal deposition disease and pseudogout of the acromioclavicular joint: radiographic and pathologic features.
J Rheumatol. 1993 Dec;20(12):2077-82.
4
Concurrence of rheumatoid arthritis and calcium pyrophosphate deposition disease: A case collection and review of the literature.
Semin Arthritis Rheum. 2018 Aug;48(1):9-11. doi: 10.1016/j.semarthrit.2017.11.009. Epub 2017 Dec 2.
5
Acute pseudogout in chronic renal failure.
Arch Intern Med. 1979 Jul;139(7):795-6.
6
Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)?
Clin Exp Rheumatol. 2009 Nov-Dec;27(6):940-4.
7
Calcium pyrophosphate crystal deposition disease and hyperparathyroidism: a controlled, prospective study.
J Rheumatol. 1978 Winter;5(4):460-8.
8
Tophaceous pseudogout of the thoracic spine.
Acta Neurochir (Wien). 2012 Apr;154(4):747-50; discussion 750. doi: 10.1007/s00701-012-1308-2. Epub 2012 Feb 27.
9
Palindromic syndrome: appearance of chondrocalcinosis after 47 years of evolution.
J Rheumatol. 1993 Sep;20(9):1610-2.
10
Posterior interosseous nerve syndrome due to pseudogout.
J Hand Surg Br. 1999 Feb;24(1):125-7. doi: 10.1054/jhsb.1998.0045.
引用本文的文献
1
Paraneoplastic arthritides: an up-to-date case-based systematic review.
Reumatologia. 2022;60(6):422-436. doi: 10.5114/reum.2022.123672. Epub 2022 Dec 30.
2
Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence.
J Rheumatol. 2020 Aug 1;47(8):1261-1266. doi: 10.3899/jrheum.190778. Epub 2019 Nov 1.
3
Pseudogout: An Autoimmune Paraneoplastic Manifestation of Myelodysplastic Syndrome.
Cureus. 2018 Sep 27;10(9):e3372. doi: 10.7759/cureus.3372.
本文引用的文献
1
Calcium Pyrophosphate Deposition Disease.
N Engl J Med. 2016 Jun 30;374(26):2575-84. doi: 10.1056/NEJMra1511117.
2
Autoimmunity and Inflammation in Myelodysplastic Syndromes.
Acta Haematol. 2016;136(2):108-17. doi: 10.1159/000446062. Epub 2016 Jun 24.
3
Recent developments in myelodysplastic syndromes.
Blood. 2014 Oct 30;124(18):2793-803. doi: 10.1182/blood-2014-04-522136. Epub 2014 Sep 18.
4
Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.
Medicine (Baltimore). 2014 Jan;93(1):1-10. doi: 10.1097/MD.0000000000000011.
5
Revised international prognostic scoring system for myelodysplastic syndromes.
Blood. 2012 Sep 20;120(12):2454-65. doi: 10.1182/blood-2012-03-420489. Epub 2012 Jun 27.
6
EULAR recommendations for calcium pyrophosphate deposition. Part II: management.
Ann Rheum Dis. 2011 Apr;70(4):571-5. doi: 10.1136/ard.2010.139360. Epub 2011 Jan 20.
7
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.
Ann Rheum Dis. 2011 Apr;70(4):563-70. doi: 10.1136/ard.2010.139105. Epub 2011 Jan 7.
8
Consecutive pseudogout attacks after repetitive granulocyte colony-stimulating factor administration for neutropenia.
Mod Rheumatol. 2007;17(5):445-6. doi: 10.1007/s10165-007-0601-z. Epub 2007 Oct 19.
Zotero 插件